Etravirine - redOrbit

News - Etravirine

FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1, Following Priority Review

2012-03-27 02:27:10

TITUSVILLE, N.J., March 27, 2012 /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S.

FDA Approves One-Pill, Once-Daily ViramuneÂ® XR(TM) (nevirapine) Extended-Release Tablets for Use in Combination With Other Antiretroviral Agents for Treatment of HIV-1 Infection in Adults

2011-04-04 16:38:00

RIDGEFIELD, Conn., April 4, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S.

Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment

2011-01-27 07:53:00

CORK, Ireland, Jan.

FDA Approves New Dosage Strength for INTELENCEÂ®

2011-01-03 07:45:00

TITUSVILLE, N.J., Jan. 3, 2011 /PRNewswire/ -- The U.S.

New Study Compares Efficacy and Safety of Once-Daily Versus Twice-Daily PREZISTA(R) Regimen in Treatment-Experienced Adult Patients With No PREZISTA Mutations

2010-02-17 15:10:00

SAN FRANCISCO, Feb.

More News (39 articles) »